World's Best Scientists 2026 revealed!
Stefano Del Prato

Stefano Del Prato

D-Index & Metrics

Medicine

D-Index
97
Citations
45831
World Ranking
9121
National Ranking
314

Overview

Stefano Del Prato is affiliated with the University of Pisa in Italy and has an extensive publication record in the field of medicine, focusing primarily on endocrinology, diabetes, and metabolism. Their research contributions cover a wide spectrum of topics centered on diabetes treatment, management, and associated metabolic conditions.

Their work spans multiple subfields including endocrinology, diabetes and metabolism, surgery, molecular biology, cardiology and cardiovascular medicine, and physiology. Major thematic areas in their publications include diabetes treatment and management, diabetes management and research, metabolism related to diabetes and cancer, pancreatic function and diabetes, diet and metabolism studies, diabetes and associated disorders, and cardiovascular function and risk factors.

Stefano Del Prato has frequently published in the following venues:

  • Diabetes
  • Diabetes Care
  • Diabetes Obesity and Metabolism
  • Diabetologia
  • Diabetes Research and Clinical Practice

Their research collaborations include frequent co-authorships with Julio Rosenstock, Cristina Bianchi, Giuseppe Penno, Monia Garofolo, and Carolyn S.P. Lam.

Key papers associated with Stefano Del Prato include:

  • Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), 2022, Diabetes Care
  • Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials, 2021, The Lancet Diabetes & Endocrinology
  • COVID-19 in people with diabetes: understanding the reasons for worse outcomes, 2020, The Lancet Diabetes & Endocrinology
  • Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), 2022, Diabetologia
  • New-Onset Diabetes in Covid-19, 2020, New England Journal of Medicine

Best Publications

  • Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future

    Steven E Kahn;Mark E Cooper;Stefano Del Prato

  • Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: a Joint Statement by International Diabetes Organizations.

    Francesco Rubino;David M Nathan;Robert H Eckel;Philip R Schauer

  • Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    Adrian F Hernandez;Jennifer B Green;Salim Janmohamed;Ralph B D'Agostino

  • How Do We Define Cure of Diabetes

    John B. Buse;Sonia Caprio;William T. Cefalu;Antonio Ceriello

  • Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations

    Francesco Rubino;David M. Nathan;Robert H. Eckel;Philip R. Schauer

  • Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes

    Valeriya Lyssenko;Roberto Lupi;Piero Marchetti;Silvia Del Guerra

  • COVID-19 in people with diabetes: understanding the reasons for worse outcomes.

    Matteo Apicella;Maria Cristina Campopiano;Michele Mantuano;Laura Mazoni

  • Prolonged Exposure to Free Fatty Acids Has Cytostatic and Pro-Apoptotic Effects on Human Pancreatic Islets: Evidence that β-Cell Death Is Caspase Mediated, Partially Dependent on Ceramide Pathway, and Bcl-2 Regulated

    Roberto Lupi;Francesco Dotta;Lorella Marselli;Silvia Del Guerra

  • Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

    Naveed Sattar;Matthew M Y Lee;Søren L Kristensen;Kelley R H Branch

  • New-Onset Diabetes in Covid-19.

    Francesco Rubino;Stephanie A. Amiel;Paul Zimmet;K. George M. M. Alberti

  • Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients

    Francesco Dotta;Stefano Censini;Astrid G. S. van Halteren;Lorella Marselli

  • Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin: A randomized, 52-week, double-blind, active-controlled noninferiority trial

    Michael A. Nauck;Stefano Del Prato;Juris J. Meier;Santiago Durán-García

  • Management of type 2 diabetes: new and future developments in treatment.

    Abd A Tahrani;Abd A Tahrani;Clifford J Bailey;Stefano Del Prato;Anthony H Barnett;Anthony H Barnett

  • Functional and Molecular Defects of Pancreatic Islets in Human Type 2 Diabetes

    Silvia Del Guerra;Roberto Lupi;Lorella Marselli;Matilde Masini

  • Obesity and insulin resistance in humans: A dose-response study☆

    Riccardo C. Bonadonna;Groop Leif;Nancy Kraemer;Eleuterio Ferrannini

  • Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes.

    Hertzel C. Gerstein;Naveed Sattar;Julio Rosenstock;Chinthanie Ramasundarahettige

  • Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man.

    S. Del Prato;F. Leonetti;D. C. Simonson;P. Sheehan

  • Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin.

    Piero Marchetti;Silvia Del Guerra;Lorella Marselli;Roberto Lupi

  • Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

    Alan J Garber;Allen B King;Stefano Del Prato;Seamus Sreenan

  • Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial.

    Stefano Del Prato;Steven E Kahn;Imre Pavo;Govinda J Weerakkody

Frequent Co-Authors

Piero Marchetti
Piero Marchetti University of Pisa
Julio Rosenstock
Julio Rosenstock The University of Texas Southwestern Medical Center
Enzo Bonora
Enzo Bonora University of Verona
Giorgio Sesti
Giorgio Sesti Sapienza University of Rome
Itamar Raz
Itamar Raz Hebrew University of Jerusalem
Ralph A. DeFronzo
Ralph A. DeFronzo The University of Texas Health Science Center at San Antonio
Lawrence A. Leiter
Lawrence A. Leiter University of Toronto
Angelo Avogaro
Angelo Avogaro University of Padua
Robert R. Henry
Robert R. Henry University of California, San Diego

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in Medicine or want to supplement your medical education, there are several flexible online pathways to advance your qualifications. For those who are already licensed nurses, enrolling in the shortest dnp programs can expedite your journey towards advanced practice and leadership roles. These programs are designed to be intensive yet efficient, allowing you to earn a Doctor of Nursing Practice degree quickly.

For students seeking a more accessible route, dnp programs online offer flexible schedules, making advanced education possible alongside professional and personal commitments. These programs are well-suited for nurses looking to enhance their clinical expertise with minimal disruption to their work-life balance.

If you’re at the start of your nursing journey, fast track lpn programs provide a quick entry-point into healthcare, enabling you to gain hands-on experience and enter the workforce sooner.

Specializing further, the fastest online pmhnp programs allow qualified nurses to focus on psychiatric mental health, addressing an urgent need in today’s healthcare landscape. These online options combine speed with quality and flexibility, making them ideal for today’s aspiring healthcare professionals.

Best Scientists Citing Stefano Del Prato

Trending Scientists

Recently Published Articles